TY - JOUR
T1 - The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia
AU - Novakovic, Tanja
AU - Martin, Antony P.
AU - Parker, Mark
AU - Ferrario, Alessandra
AU - Vukovic, Simo
AU - Łanda, Krzysztof
AU - Duba, Jaroslav
AU - Dankó, Dávid
AU - Kotsopoulos, Nikolaos
AU - Godman, Brian
AU - Ristic, Jelena
AU - Stefanovic, Danka
AU - Tesic, Danka
N1 - Funding Information:
aPharmacoeconomics Section, Pharmaceutical Association of Serbia, Belgrade, Serbia; bLiverpool Health Economics Centre, Liverpool University, Liverpool, UK; cZem Solutions d.o.o., Belgrade, Serbia; dDepartment of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute, Harvard University, Boston, USA; eSecond Serbian Health Project, Ministry of Health, Belgrade, Serbia; fNational Center of Research & Development (NCBiR) of the Republic of Poland, Warsaw, Poland; gOAKS Consulting, Czech Republic; hInstitute of Management, Corvinus University of Budapest, Budapest, Hungary; iGlobal Market Access Solutions, Mooresville, NC, USA; jSchool of Public Policy and Administration, University of Athens, Athens, Greece; kDivision of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden; lDepartment of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK
Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2017/11/2
Y1 - 2017/11/2
N2 - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
AB - The Pharmacoeconomics Section of the Pharmaceutical Association of Serbia organised a one day international conference on the value of innovation in decision-making in health care in Central and Eastern Europe. The focus of the conference was on reimbursement decisions for medicines using health technology assessment and the use of managed entry agreements (MEAs). The objectives of this conference were firstly to discuss the challenges and opportunities with the use of MEAs in Central and Eastern European countries; secondly the role of patient registries especially with outcome based schemes, and finally new approaches to improve accessibility to new medicines including better managing their entry.
KW - Central and Eastern Europe
KW - Serbia
KW - health technology assessment
KW - innovation
KW - managed entry agreements
UR - http://www.scopus.com/inward/record.url?scp=85030871262&partnerID=8YFLogxK
U2 - 10.1080/14737167.2017.1385394
DO - 10.1080/14737167.2017.1385394
M3 - Article
C2 - 28946800
AN - SCOPUS:85030871262
SN - 1473-7167
VL - 17
SP - 519
EP - 521
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 6
ER -